Kim · Archives of pharmacal research 2012 · Preclinical animal and in vitro mechanistic study · n=?

Enhancement of pentobarbital-induced sleep by apigenin through chloride ion channel activation.

Cited 27 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical animal behavior and in vitro cell culture study with no human data.

PubMed 22370792 · doi:10.1007/s12272-012-0218-4 · record verified 2026-08-27

What was done

Researchers evaluated the hypnotic and pentobarbital-potentiating effects of apigenin in mice, both alone and alongside the GABAA agonist muscimol. They assessed chloride ion influx in primary cultured cerebellar granule cells exposed to apigenin and measured glutamate decarboxylase (GAD) and GABAA receptor alpha-, beta-, and gamma-subunit expression in mouse hippocampus.

What was found

The abstract reports no numerical values or confidence intervals. Apigenin prolonged pentobarbital-induced sleep duration, increased sleep rate and sleep time when combined with sub-hypnotic pentobarbital doses, and acted synergistically with muscimol on sleep onset and duration. In cell culture, apigenin increased chloride influx in primary cerebellar granule cells. In mouse hippocampus, apigenin upregulated GAD without altering GABAA receptor alpha-, beta-, or gamma-subunit expression.

Why it matters

The findings outline a potential GABAergic and chloride-channel mechanism through which the plant flavonoid apigenin may modulate sleep behaviors.

Limits

The study was conducted entirely in mice and in vitro cell cultures, preventing direct translation to human clinical sleep outcomes. The abstract omits sample sizes, specific dosage regimens, quantitative effect sizes, and statistical variance metrics.

Cited by